PTGS2 and neoplasm: Another study found that COX-2 knockdown in tumor cells suppressed tumor growth and increased the number of tumor-infiltrating cytotoxic CD8+ T cells, which led to an improvement in immunotherapy in pancreatic mouse models [73].